Clinical Trial: A multicenter, randomized, double-blind, double-dummy, parallel, active-controlled clinical trial to evaluate the efficacy and safety of morphine sulfate extended-release capsules in patients with moderate to severe cancer pain (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter, randomized, double-blind, double-dummy, parallel, active-controlled clinical trial to evaluate the efficacy and safety of morphine sulfate extended-release capsules in patients with moderate to severe cancer pain'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132985

Registration Time: 2026/09/20

Type: Interventional study

Primary Sponsor: zhengzhou Third People's Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=264665

Published by HT Digital Content Services with permission from Health Daily Digest....